A-101 Topical Solution
A-101-SEBK-402
Approved small_molecule completed
Quick answer
A-101 Topical Solution for Seborrheic Keratosis is a Approved program (small_molecule) at Aclaris Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aclaris Therapeutics
- Indication
- Seborrheic Keratosis
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed